216 related articles for article (PubMed ID: 16571777)
1. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis.
Deindl E; Zaruba MM; Brunner S; Huber B; Mehl U; Assmann G; Hoefer IE; Mueller-Hoecker J; Franz WM
FASEB J; 2006 May; 20(7):956-8. PubMed ID: 16571777
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
[TBL] [Abstract][Full Text] [Related]
3. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
Ohtsuka M; Takano H; Zou Y; Toko H; Akazawa H; Qin Y; Suzuki M; Hasegawa H; Nakaya H; Komuro I
FASEB J; 2004 May; 18(7):851-3. PubMed ID: 15001565
[TBL] [Abstract][Full Text] [Related]
4. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia.
Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Ma A; Liu Z
J Cardiol; 2013 Jan; 61(1):87-94. PubMed ID: 23085036
[TBL] [Abstract][Full Text] [Related]
5. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
[TBL] [Abstract][Full Text] [Related]
6. The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor release.
Brunner S; Weinberger T; Huber BC; Segeth A; Zaruba MM; Theiss HD; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2012 Feb; 93(2):330-9. PubMed ID: 22080594
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
[TBL] [Abstract][Full Text] [Related]
11. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
[TBL] [Abstract][Full Text] [Related]
14. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
[TBL] [Abstract][Full Text] [Related]
15. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
Kuhlmann MT; Kirchhof P; Klocke R; Hasib L; Stypmann J; Fabritz L; Stelljes M; Tian W; Zwiener M; Mueller M; Kienast J; Breithardt G; Nikol S
J Exp Med; 2006 Jan; 203(1):87-97. PubMed ID: 16401694
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
Ripa RS
Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
18. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
19. G-CSF after myocardial infarction accelerates angiogenesis and reduces fibrosis in swine.
Sato T; Suzuki H; Kusuyama T; Omori Y; Soda T; Tsunoda F; Shoji M; Iso Y; Koba S; Geshi E; Katagiri T; Kawachi K; Wakabayashi K; Takeyama Y
Int J Cardiol; 2008 Jul; 127(2):166-73. PubMed ID: 17692407
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
